A carregar...
Olopatadine ophthalmic solution suppresses substance P release in the conjunctivitis models
BACKGROUND: Olopatadine hydrochloride ophthalmic solutions are treated for allergic conjunctival diseases that are a selective histamine H1 receptor antagonist and an inhibitor of the release of mediators including histamine from the human mast cells. Substance P (SP) levels are increased in tears o...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Asia Pacific Association of Allergy, Asthma and Clinical Immunology
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3345324/ https://ncbi.nlm.nih.gov/pubmed/22701861 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5415/apallergy.2012.2.2.115 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|